Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
The LEAN trial with liraglutide and a phase 2 trial of semaglutide in patients with non-alcoholic steatohepatitis (NASH) showed improvements in liver histology and reductions in hepatic inflammation markers
Increased heart rate : A small increase in resting heart rate has been observed as a class effect with incretin-based therapies
Understanding how to maintain balanced nutrition whilst on these medications is crucial for optimising both metabolic health and treatment outcomes
Visit Doctronic.ai to explore side effects, get treatment recommendations, or schedule a telehealth visit
US$ 29.77
US$ 26.73
US$ 26.48
.png)
US$ 29.68
